Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Tuhura Biosciences Inc (HURA)

Tuhura Biosciences Inc (HURA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
3.53 -0.09 (-2.49%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 3.40 -0.13 (-3.68%) 19:00 ET
Quote Overview for Fri, Mar 28th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
3.41
Day High
3.61
Open 3.61
Previous Close 3.62 3.62
Volume 131,200 131,200
Avg Vol 280,905 280,905
Stochastic %K 80.29% 80.29%
Weighted Alpha -69.21 -69.21
5-Day Change +0.20 (+6.01%) +0.20 (+6.01%)
52-Week Range 1.80 - 14.60 1.80 - 14.60
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 149,266
  • Shares Outstanding, K 42,285
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,320 K
  • EBIT $ -8 M
  • EBITDA $ -8 M
  • 60-Month Beta 1.02
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.15
  • Number of Estimates 2
  • High Estimate -0.09
  • Low Estimate -0.20
  • Prior Year -8.39
  • Growth Rate Est. (year over year) +98.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.80 +96.11%
on 03/10/25
Period Open: 2.41
4.00 -11.75%
on 03/20/25
+1.12 (+46.47%)
since 02/28/25
3-Month
1.80 +96.11%
on 03/10/25
Period Open: 4.41
5.50 -35.82%
on 01/10/25
-0.88 (-19.95%)
since 12/27/24
52-Week
1.80 +96.11%
on 03/10/25
Period Open: 3.64
14.60 -75.81%
on 05/30/24
-0.11 (-3.02%)
since 03/28/24

Most Recent Stories

More News
Small Cap News Movers: Your Weekly Digest of Stocks Making Moves on Market News

This week, the stock market faced a downturn as major indices struggled to maintain momentum. The S&P 500 (SPX), Dow Jones Industrial Average (DJI), and NASDAQ Composite (IXIC) all ended in the red, weighed...

DGNX : 94.90 (-6.04%)
QBTS : 7.58 (-5.96%)
RDUS : 28.98 (-0.34%)
WLGS : 0.2600 (-10.65%)
HURA : 3.53 (-2.49%)
RGS : 18.20 (-3.55%)
Small Cap News Movers: Your Weekly Digest of Stocks Making Moves on Market News

This week, the stock market faced a downturn as major indices struggled to maintain momentum. The S&P 500 (SPX), Dow Jones Industrial Average (DJI), and NASDAQ Composite (IXIC) all ended in the red, weighed...

DGNX : 94.90 (-6.04%)
QBTS : 7.58 (-5.96%)
RDUS : 28.98 (-0.34%)
WLGS : 0.2600 (-10.65%)
HURA : 3.53 (-2.49%)
RGS : 18.20 (-3.55%)
TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors

Dr. Tendler oversaw 30 Major Drug Approvals, including worldwide approvals for J&J's transformational treatments in hematologic malignancies, prostate, lung and bladder cancers

HURA : 3.53 (-2.49%)
TuHURA Biosciences, Inc. to Present at the 37th Annual ROTH Conference

Live webcast fireside chat on Tuesday, March 18th at 8:30 AM PT

HURA : 3.53 (-2.49%)
TuHURA Biosciences, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference

On-demand video webcast now available here

HURA : 3.53 (-2.49%)
Virtual Investor "Top 5 for '25" Conference Hosted by JTC Now Available On-Demand

- Access video webcasts from the first wave of participating companies here

AKTX : 1.2700 (-2.31%)
AREC : 0.4900 (-7.55%)
OTLK : 1.3200 (-5.71%)
AMIX : 1.8300 (-4.19%)
CNSP : 1.3000 (-1.52%)
PALI : 0.6887 (-0.12%)
NVNO : 2.75 (-2.83%)
HURA : 3.53 (-2.49%)
GRI : 4.37 (-25.61%)
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.

Opportunistic acquisition adds Phase 2 novel checkpoint inhibitor (KVA12123) to TuHURA's late stage pipeline

HURA : 3.53 (-2.49%)
KANT : 0.3459 (+11.94%)
TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell Carcinoma and Provides Business Update

IFx-2.0, a first-in-class innate immune response agonist, entering single Phase 3 accelerated approval registration trial in first half of 2025 for first line treatment of Merkel Cell Carcinoma (MCC) under...

HURA : 3.53 (-2.49%)
KANT : 0.3459 (+11.94%)
TuHURA Biosciences (Nasdaq: HURA) Announces Webcast Replay of Panel Presentation at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC

TAMPA, FL / ACCESSWIRE / October 23, 2024 / TuHURA Biosciences, Inc. (Nasdaq:HURA) ("TuHURA" or the "Company"), a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome...

HURA : 3.53 (-2.49%)

Business Summary

TuHURA Biosciences Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's lead personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. TuHURA...

See More

Key Turning Points

3rd Resistance Point 3.82
2nd Resistance Point 3.72
1st Resistance Point 3.62
Last Price 3.53
1st Support Level 3.42
2nd Support Level 3.32
3rd Support Level 3.22

See More

52-Week High 14.60
Fibonacci 61.8% 9.71
Fibonacci 50% 8.20
Fibonacci 38.2% 6.69
Last Price 3.53
52-Week Low 1.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies